SequelSEC

RETRACTABLE TECHNOLOGIES INC RVP

Surgical & Medical Instruments & Apparatus · CIK 0000946563 · Fiscal year ends 1231

Revenue
$33.90M
Fiscal year ended 2026-06-30
Operating income
-$22.68M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

RETRACTABLE TECHNOLOGIES INC (RVP) reported revenue of $33.90M and net income of -$3.37M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from RETRACTABLE TECHNOLOGIES INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

RETRACTABLE TECHNOLOGIES INC income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$33.90M
Cost of revenue$34.39M
Gross profit-$491.51K
Operating income-$22.68M
Net income-$3.37M
Research & development$682.03K
Weighted-average diluted sharesUnavailable
Pretax income-$3.36M
Income tax expense$7.39K
Diluted EPSUnavailable
Selling, general & administrative$20.55M
General & administrative$13.73M
Selling & marketing$6.83M

Balance

RETRACTABLE TECHNOLOGIES INC balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$2.64M
Total assets$141.69M
Current assets$65.92M
Total liabilities$68.83M
Current liabilities$13.37M
Total equity incl. NCI$72.87M
Temporary (mezzanine) equityUnavailable
Inventory$15.93M
Accounts receivable$9.03M
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$6.70M

Cash flow

RETRACTABLE TECHNOLOGIES INC cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$4.96M
Capital expendituresUnavailable
Investing cash flow$5.18M
Financing cash flow-$632.04K
Net change in cash-$403.94K
Stock-based compensationUnavailable
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$7.81M

Derived

RETRACTABLE TECHNOLOGIES INC derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin-1.4%
Operating margin-66.9%
FCF marginUnavailable
SBC / revenueUnavailable
Current ratio4.93x
Revenue YoY growth-11.2%
Net margin-9.9%
R&D / revenue2.0%
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open RVP in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-05-15View SEC filing
10-K · Filed 2026-03-27View SEC filing
10-Q · Filed 2025-11-14View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-05-15View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.